Category Archives: Office Web Apps

The 10 best stock pickers that you should have listened to in 2016 (REI, ECA, GNW, SIVB, TBK, AMD, GNMK, FMSA, CDE, AMBR)

apple picking

Wall Street’s sell-side analysts publish piles of recommendations on which stocks to buy, sell, or hold every day.

In retrospect, and for the trader with a shorter time horizon, only a few of those calls were worth listening to in 2016.

TipRanks, a website that tracks and ranks analyst recommendations, compiled a list of stock pickers who had the most success last year.

After scanning hundreds of thousands of recommendations, TipRanks graded them by average return and success rate, which is the ratio of calls that generated positive returns in the following quarter relative to all ratings that were given.

Recommendations were measured for a three-month period from the open date in 2016 or until January 11, if the three months are still ongoing. 

Here are the stock pickers, ranked by average return of their calls:

10. Michael Matson, Needham

Industry: Healthcare

Success Rate: 62%

Average Return: 9%

Noteworthy recommendation: GenMark (GNMK)

Matson’s most profitable recommendation of 2016 (with a three-month profit of 72.7%) was for molecular diagnostic testing company GenMark on April 19. He has subsequently reiterated his buy rating twice — most recently on July 29 after the European clearance and launch of GNMK’s sample-to-answer ePlex system. At the end of last year, GenMark submitted ePlex to the FDA for clearance.

9. Christopher Nolan, FBR

Industry: Financial

Success Rate: 87%

Average Return: 11.5%

Noteworthy recommendation: Triumph Bancorp (TBK)

Nolan’s buy recommendation of Texas-based Triumph Bancorp on Nov. 27 was his most profitable call of the last year. From the end of Nov until Jan. 11 the shares made 39.9% profit.

According to Nolan, 3Q16 earnings were solid with EPS of $0.32 above estimates (excluding merger-related expenses from the acquisition of ColoEast Bancshares in August). However, “asset quality deteriorated in terms of higher nonperforming assets (NPA) and net charge-offs mostly related to legacy TBK credit,” said Nolan.

8. Mark Palmer, BTIG


Industry: Financial

Success Rate: 78%

Average Return: 14.2%

Noteworthy recommendation: Genworth Financial (GNW)

Palmer maintained his Buy rating on the insurance company’s stock on February 5. This turned out to be a very good decision — the stock gained 78% in the three months after the call with the share price rising from $2.18 to $4.06. 

However, Palmer has recently downgraded his Genworth rating to hold following the announcement in October of its acquisition by China Oceanwide for $5.43 per share in cash.

See the rest of the story at Business Insider

Microsoft Office 2010
Polycom Cx5000 Unified Conference Station For Microsoft Lync (Amazon) Amazon Logo

$4300.00



Buy Now

Microsoft Surface (32gb) (Amazon) Amazon Logo

$539.95



Buy Now

+ 11 others available from Amazon
Microsoft Office Home & Business 2010 - 2pc/1user (one Desktop And One Portable) (disc Version) (Amazon) Amazon Logo

$278.00

Buy Now
Microsoft Software Office Home And Business 2010 English Pc Attach Key Product Key Card For 1pc (Amazon) Amazon Logo

$219.69

Buy Now
Microsoft Office Home & Student 2010 - 3pc/1user (disc Version) (Amazon) Amazon Logo

$179.99

Buy Now
Microsoft Office Home & Business 2010 Product Key Card- 1pc/1user [download] (Amazon) Amazon Logo

$150.09

Buy Now
Go! With Microsoft Office 2010, Vol. 1, And Student Videos (Amazon) Amazon Logo

$128.49



Buy Now

Microsoft Office Home & Student 2010 - 3pc/1user [download] (Amazon) Amazon Logo

$124.99

Buy Now
Microsoft Office Home & Student 2010 Product Key Card- 1pc/1user [download] (Amazon) Amazon Logo

$99.99

Buy Now
New Perspectives On Microsoft Office 2010, First Course (Amazon) Amazon Logo

$87.20



Buy Now

Microsoft Natural Ergonomic Desktop 7000 (Amazon) Amazon Logo

$81.78



Buy Now

Microsoft Office 2010: Introductory (shelly Cashman Series(r) Office 2010) (Amazon) Amazon Logo

$69.49



Buy Now

Technorati Tags: , , , , ,

AT&T CEO says he won't need to spin off CNN for the $85 billion Time Warner merger to go through (T, TWX)

AT&T CEO Randall Stephenson (L) and Time Warner Inc CEO Jeff Bewkes discuss their companies' proposed merger at the WSJD Live conference in Laguna Beach, California October 25, 2016.     REUTERS/Mike Blake

AT&T doesn’t need to get rid of CNN in order for its proposed $85 billion merger with Time Warner to go through, according to AT&T CEO Randall Stephenson.

In an interview with CNBC, Stephenson said spinning off CNN “doesn’t seem relevant to approving a deal like this.”

Stephenson continued with his argument that the deal is a vertical integration, meaning two different types of companies coming together without removing competition from the market.

“The market concentrations are the same. Nothing is different,” Stephenson said.

Last week, some speculated that AT&T would have to agree to spin off CNN in order to get the Time Warner deal approved, since President-elect Trump has said both publicly and privately (according to Bloomberg) that he’s not a fan of the deal. And we all know how Trump feels about CNN.

Stephenson met with Trump in New York last week, but it’s unclear what the two specifically discussed.

SEE ALSO: The inventor of Android is working on a new smartphone

Join the conversation about this story »

NOW WATCH: AT&T CEO: Trump is a ‘positive development’ for our industry

Microsoft Office 2010
Polycom Cx5000 Unified Conference Station For Microsoft Lync (Amazon) Amazon Logo

$4300.00



Buy Now

Microsoft Surface (32gb) (Amazon) Amazon Logo

$539.95



Buy Now

+ 11 others available from Amazon
Microsoft Office Home & Business 2010 - 2pc/1user (one Desktop And One Portable) (disc Version) (Amazon) Amazon Logo

$278.00

Buy Now
Microsoft Software Office Home And Business 2010 English Pc Attach Key Product Key Card For 1pc (Amazon) Amazon Logo

$219.69

Buy Now
Microsoft Office Home & Student 2010 - 3pc/1user (disc Version) (Amazon) Amazon Logo

$179.99

Buy Now
Microsoft Office Home & Business 2010 Product Key Card- 1pc/1user [download] (Amazon) Amazon Logo

$150.09

Buy Now
Go! With Microsoft Office 2010, Vol. 1, And Student Videos (Amazon) Amazon Logo

$128.49



Buy Now

Microsoft Office Home & Student 2010 - 3pc/1user [download] (Amazon) Amazon Logo

$124.99

Buy Now
Microsoft Office Home & Student 2010 Product Key Card- 1pc/1user [download] (Amazon) Amazon Logo

$99.99

Buy Now
New Perspectives On Microsoft Office 2010, First Course (Amazon) Amazon Logo

$87.20



Buy Now

Microsoft Natural Ergonomic Desktop 7000 (Amazon) Amazon Logo

$81.78



Buy Now

Microsoft Office 2010: Introductory (shelly Cashman Series(r) Office 2010) (Amazon) Amazon Logo

$69.49



Buy Now

Technorati Tags: , , , , ,

A single dose of psychedelics might act like a 'kick-start' for the brain — and researchers want to use it to treat mental illness

meditate

Estalyn Walcoff arrived at the nondescript beige building in Manhattan’s Grammercy Park neighborhood on a balmy August morning, hours before the city would begin to swell with the frenetic energy of summer tourists. She was about to face a similar type of chaos — but only in her mind.

Pushing open the door to the Bluestone Center at the New York University College of Dentistry, Walcoff entered what looked like an average 1970s living room. A low-backed brown couch hugged one wall. On either side, a dark brown table held a homely lamp and an assortment of colorful, hand-painted dishes. A crouching golden Buddha, head perched thoughtfully on its knee, adorned another table closer to the entrance.

Months before, Walcoff had volunteered to participate in a study of how the psychedelic drug psilocybin, the main psychoactive ingredient in magic mushrooms, affects the brain in cancer patients with anxiety and depression. The promising results of that five-year study, published earlier this month, have prompted some researchers to liken the treatment to a “surgical intervention.”

The researchers believe they are on the cusp of nothing less than a breakthrough: A single dose of psychedelic drugs appears to alleviate the symptoms of some of the most common, perplexing, and tragic illnesses of the brain. With depression the leading cause of disability worldwide, the timing seems ideal.

In people like Walcoff, whose depression and anxiety struck them like a powerful blow following a cancer diagnosis, one dose of psilocybin seemed to quiet her existential dread, to remind her of her connectedness with the world around her, and perhaps most importantly, to reassure her of her place in it.

And these results don’t seem to be limited to people with cancer or another life-threatening illness. Participants in a handful of other psychedelic studies consistently ranked their trip as one of their most meaningful life experiences — not only because of the trip itself, but because of the changes they appear to produce in their lives in the months and years afterward.

Still, the existing research is limited — which is why, scientists say, they so badly need permission from the government to do more.

Clark’s story

1990 was a year of life and death for Clark Martin. It was the year his daughter was born and the year he was diagnosed with cancer.

Over the next twenty years, as his daughter took her first steps, experienced her first day of school, and eventually began growing into a smart, fiercely independent teenager, doctors waged a blitzkrieg on Martin’s body. Six surgeries. Two experimental treatments. Thousands of doctor’s visits. The cancer never went into remission, but Martin and his doctors managed to keep it in check by staying vigilant, always catching the disease just as it was on the brink of spreading.

Still, the cancer took its toll. Martin was riddled with anxiety and depression. He’d become so focused on saving his body from the cancer that he hadn’t made time for the people and things in his life that really mattered. His relationships were in shambles; he and his daughter barely spoke.

So in 2010, after reading an article in a magazine about a medical trial that involved giving people with cancer and anxiety the drug psilocybin, he contacted the people running the experiment and asked to be enrolled.

After weeks of lengthy questionnaires and interviews, he was selected. On a chilly December morning, Martin walked into the facility at Johns Hopkins, where he was greeted by two researchers including Johns Hopkins psychologist Bill Richards. The three of them sat and talked in the room for half an hour, going over the details of the study and what might happen.

Martin then received a pill and swallowed it with a glass of water. For study purposes, he couldn’t know whether it was a placebo or psilocybin, the drug the researchers aimed to study.

Next, he lay back on the couch, covered his eyes with the soft shades he’d been given, and waited.

sailboat alone sunset sea ocean solitude lonely old man and the seaWithin a few minutes, Martin began to feel a sense of intense panic.

“It was quite anxiety provoking. I tried to relax and meditate but that seemed to make it worse and I just wanted everything to snap back into place. There was no sense of time and I realized the drug was in me and there was no stopping it.”

Martin, an avid sailor, told me it reminded him of a frightening experience he’d had once when, after being knocked off his boat by a wave, he’d become suddenly disoriented and lost track of the boat, which was floating behind him.

“It was like falling off the boat in the open ocean, looking back, and the boat is gone. And then the water disappears. Then you disappear.”

Martin was terrified, and felt on the verge of a “full-blown panic attack.” Thanks to the comfort and guidance of his doctors, however, he was eventually able to calm down. Over the next few hours, the terror vanished. It was replaced with a sense of tranquility that Martin still has trouble putting into words.

“With the psilocybin you get an appreciation — it’s out of time — of well-being, of simply being alive and a witness to life and to everything and to the mystery itself,” said Martin.

Lots of things happened to Martin over the course of his four-hour trip. For a few hours, he remembers feeling a sense of ease; he was simultaneously comfortable, curious, and alert. At one point, he recalls a vision of being in a sort of cathedral where he asked God to speak to him. More than anything else, though, he no longer felt alone.

“The whole ‘you’ thing just kinda drops out into a more timeless, more formless presence,” Martin said.

Over the next few hours, as his trip slowly began to draw to a close and he began to return to reality, Martin recalls a moment where the two worlds — the one in which he was hallucinating and the reality he could call up willingly from memory — seemed to merge. He turned his attention to his relationships. He thought of his daughter. His friends. His co-workers.

“In my relationships I had always approached it from a, ‘How do I manage this?’, How do I present myself?,’ ‘Am I a good listener?’, type of standpoint. But it dawned on me as I was coming out of [the trip] that relationships are pretty much spontaneous if you’re just present and connecting,” said Martin.

That shift, which Martin stresses has continued to deepen since he took the psilocybin in 2010, has had enduring implications for his relationships.

“Now if I’m meeting people, the default is to be just present, not just physically, but mentally present to the conversation. That switch has been profound.”

While he felt himself undergo a shift during his 4-hour trip on psilocybin, Martin says the most enduring changes in his personality and his approach to those around him have continued to unfold in the months and years after he took the drug. For him, the drug was merely a catalyst; a “kick-start,” he likes to call it. By temporarily redirecting his perspective within the span of few hours, Martin believes it unleashed a chain reaction in the way he sees and approaches the world.

This squares with what researchers have found by looking at the brain on psilocybin.

Taking the road(s) less traveled

Ask a healthy person who’s “tripped” on psychedelics what it felt like, and they’ll probably tell you they saw sounds.

The crash-bang of a dropped box took on an aggressive, dark shape. Or they might say they heard colors. A bright green light seems to emit a piercing, high-pitched screech.

In actuality, this “cross-wiring” — or synaesthesia, as it’s known scientifically — may be one example of the drug “freeing” the brain from its typical connection patterns.

This fundamental change in how the brain sends and receives information also might be the reason they’re so promising as a treatment for people with mental illnesses like depression, anxiety, or addiction. In order to understand why, it helps to take a look at how a healthy brain works.

hikerNormally, information gets exchanged in the brain using various circuits, or what one researcher described to me as “informational highways.” On some highways, there’s a steady stream of traffic. On others, however, there’s rarely more than a few cars on the road. Psychedelics appear to drive traffic to these underused highways, opening up dozens of different routes to new traffic and freeing up some space along the more heavily-used ones.

Dr. Robin Cahart-Harris, who leads the psychedelic research arm of the Center for Neuropsychopharmacology at Imperial College London, captured these changes in one of the first neuroimaging studies of the brain on a psychedelic trip. He presented his findings at a conference on the therapeutic potential of psychedelics in New York City last year. “[With the psilocybin] there was a definite sense of lubrication, of freedom, of the cogs being loosened and firing in all sorts of unexpected directions,” said Cahart-Harris.

This might be just the kick-start that a depressed brain needs.

One key characteristic of depression is overly-strengthened connections between brain circuits in certain regions of the brain — particularly those involved in concentration, mood, conscious thought, and the sense of self. And in fact, this may be part of the reason that electroconvulsive therapy, which involves placing electrodes on the temples and delivering a small electrical current, can help some severely depressed people — by tamping down on some of this traffic.

“In the depressed brain, in the addicted brain, in the obsessed brain, it gets locked into a pattern of thinking or processing that’s driven by the frontal, the control center, and they cannot un-depress themselves,” David Nutt, the director of the neuropsychopharmacology unit in the Division of Brain Sciences at Imperial College London, told me.

shrooms brain networks

Nutt has been one of the pioneering researchers in the field of studying how psychedelics might be used to treat mental illness. He said that in depressed people, these overly-trafficked circuits (think West Los Angeles at rush-hour) can lead to persistent negative thoughts. Feelings of self-criticism can get obsessive and overwhelming. So in order to free someone with depression from those types of thoughts, one would need to divert traffic from some of these congested ruts and, even better, redirect it to emptier highways.

Which is precisely what psychedelics appear to do.

“Psychedelics disrupt that process so people can escape. At least for the duration of the trip they can escape about the ruminations about depression or alcohol or obsessions. And then they do not necessarily go back,” said Nutt.

A 4-hour trip, a long-lasting change

“Medically what you’re doing [with psychedelics is] you’re perturbing the system,” Paul Expert, who co-authored one of the first studies to map the activity in the human brain on psilocybin, told me over tea on a recent afternoon in London’s bustling Whitechapel neighborhood.

Expert, a physicist at the King’s College London Center for Neuroimaging Sciences, doesn’t exactly have the background you’d expect from someone studying magic mushrooms.

But it was by drawing on his background as a physicist, Expert told me, that he and his team were able to come up with a systematic diagram of what the brain looks like on a psilocybin trip. Their study, published in 2014, also helps explain how altering the brain temporarily with psilocybin can produce changes that appear to continue to develop over time.

When you alter how the brain functions (or “perturb the system,” in physicist parlance) with psychedelics, “that might reinforce some connections that already exist, or they might be more stimulated,” Expert told me.

But those changes aren’t as temporary as one might expect for a 4-hour shroom trip. Instead, they appear to catalyze dozens of other changes that deepen in the for months and years after taking the drug.

“So people who take magic mushrooms report for a long time after the actual experience that they feel better, they’re happier with life,” said Expert. “But understanding exactly why this is the case is quite tricky, because the actual trip is very short, and it’s not within that short span of time that you could actually have sort of new connections that are made. That takes much more time.”

Gong Orchid Buddha 2

The clinical trials that Walcoff and Martin took part in, which took place at NYU and Johns Hopkins over the course of five years, are the longest and most comprehensive studies of people with depression on psychedelics that we have to-date. Last year, a team of Brazilian researchers published a review of all of the clinical trials on psychedelics published between 1990 and 2015. After looking at 151 studies, the researchers were only able to find six which met their analysis criteria. The rest were either too small, too poorly-controlled, or problematic for another reason. Nevertheless, based on the six studies they were able to review, the researchers concluded that “ayahuasca, psilocybin, and LSD may be useful pharmacological tools for the treatment of drug dependence, and anxiety and mood disorders, especially in treatment-resistant patients. These drugs may also be useful pharmacological tools to understand psychiatric disorders and to develop new therapeutic agents.”

Because the existing research is so limited, scientists still can’t say exactly what is happening in the brain of someone who’s tripped on psychedelics that appears to unleash such a cascade of life changes like the kind Martin described.

What we do know, though, is that things like training for a musical instrument or learning a skill change the brain. It’s possible that psychedelics do something similar over the long-term, even if the actual trip — the phase of drug use that many people focus on — is pretty brief.

In other words, a trip “might trigger a sort of snowball effect,” said Expert, in the way the brain processes information.

And something about the experience appears to be much more powerful, for some people, than even years of antidepressants. A small recent trial of psilocybin that Nutt co-authored in people whose chronic depression had not responded to repeated attempts at treatment with medication suggested that this may be the case. While the trial was only designed to determine if the drug was safe, all of the study participants saw a significant decrease in symptoms at a one-week follow-up; the majority said they continued to see a decrease in symptoms at another follow-up done three months later.

“We treated people who’d been suffering for 30 years. And they’re getting better with a single dose,” said Nutt. “So that tells us this drug is doing something profound.”

Killing the ego

Between 1954 and 1960, Dr. Humphry Osmond gave thousands of alcoholics LSD.

It was part of an experimental treatment regimen aimed at helping them recover. Osmond thought that the acid would mimic some of the symptoms of delirium tremens, a psychotic condition common in chronic alcoholics when they try to stop drinking that can involve tremors, hallucinations, anxiety, and disorientation. Osmond thought the experience might shock the alcoholics, who’d thus far failed to respond to any other treatments, into not drinking again.

He was wrong.

Rather than terrifying his patients with an extreme case of shakes and hallucinations, the acid appeared to produce positive, long-lasting changes in their personalities. Something about the LSD appeared to help the suffering alcoholics “reorganize their personalities and reorganize their lives,” said New York University psychiatrist Michael Bogenschutz at a conference on therapeutic psychedelics last year.

A year later, 40% to 45% of Osmond’s patients had not returned to drinking — a higher success rate than any other existing treatment for alcoholism.

In an interview with the Harvard psychiatrist Dr. John Halpern, Osmond’s colleague, the biochemist Dr. Abram Hoffer, recalled, “Many of them didn’t have a terrible experience. In fact, they had a rather interesting experience.”

While some call it interesting, other have called it “spiritual,” “mystical,” or even “religious.”

Scientists still can’t say for sure what is going on in the brain during a trip that appears to produce these types of experiences. We know that part of it is about the tamping down of certain circuits and the ramping up of others.

hammock ocean

Interestingly enough, one of the circuits that appears to get quieter during a psychedelic trip is the circuit that connects the parahippocampus and the retrosplenial cortex. This network is thought to play a key role in our sense of self, or ego.

Deflating the ego is far from the soul-crushing disappointment it sounds like. Instead, it appears to make people feel more connected to the people and environment around them.

Cahart-Harris, who conducted the first study of its kind to take images of a healthy brain on LSD, said in a news release that his findings support that idea. In a normal, non-drugged person, specific parts of our brain light up with activity depending on what we’re doing. If we’re focused on reading something, the visual cortex sparkles with action. If we’re listening carefully to someone, our auditory cortex is particularly active. Under the influence of LSD, the activity isn’t as neatly segregated. “… the separateness of these networks breaks down and instead you see a more integrated or unified brain,” he said.

That change might help explain why the drug produces an altered state of consciousness too. Just as the invisible walls between once-segregated tasks are broken down, the barriers between the sense of self and the feeling of interconnection with one’s environment appear to dissolve. “The normal sense of self is broken down and replaced by a sense of re-connection with themselves, others and the natural world,”said Cahart-Harris.

Given that one of the key characteristics of mental illnesses like depression and alcoholism is isolation and loneliness, this newfound interconnection could act as a powerful antidote.

“It’s kind of like getting out of a cave. You can see the light and you can stay in the light,” said Nutt. “You’ve been liberated.”

A spiritual experience

Humans have a long history of looking to “spiritual experiences” to treat mental illness and of using psychedelics to help bring such experiences about.

Ayahuasca, a hallucinogenic beverage brewed from the macerated and boiled vines of the Banisteriopsis caapi (yagé) plant and the Psychotria viridis (chacruna) leaf, has been used as a traditional spiritual medicine in ceremonies among the indigenous peoples of Bolivia, Colombia, Ecuador, and Peru for centuries. Its name is a combination of the Quechua words “aya,”which can be loosely translated into “spirit”and “waska,”or “woody vine.”Europeans didn’t encounter ayahuasca until the 1500s, when Christian missionaries traveling through Amazonia from Spain and Portugal saw it being used by indigenous peoples. (At the time, they called it the work of the devil.)

It’s now understood that ayahuasca has a similar effect on the brain as magic mushrooms or acid. Yet unlike magic mushrooms, whose main psychoactive ingredient is the drug psilocybin, ayahuasca’s psychoactive effects come from a result of mixing two different substances — the drug dimethyltryptamine (DMT), from the chacruna plant, and the MAO-Inhibitor (MAOI), from the yage plant, which allows the DMT to be absorbed into our bloodstream.

milky way universeIn the early 1950s, in fact, writer William Burroughs traveled through South America looking for the yagé plant hoping that he could use it to help cure opiate addiction. Some fifteen years earlier, a man suffering in an alcoholic ward in New York had a transformative experience on the hallucinogen belladonna. “The effect was instant, electric. Suddenly my room blazed with an incredibly white light,” the man wrote. Shortly after that, the man, whose name was William (“Bill”) Wilson, would go on to found the 12-step recovery program Alcoholics Anonymous. Wilson later experimented with LSD and said he believed the drug could help alcoholics achieve one of the central tenets of AA: acceptance of a “power greater than ourselves.”

Nevertheless, ayahuasca, LSD, and other hallucinogens were slow to gain notoriety across Europe and North America. They saw a temporary surge in popularity in the US in the 1960s, with people like Timothy Leary and Richard Alpert writing of the “ego loss” produced by magic mushrooms as part of their Harvard Psilocybin Project. But in 1966, the US government made psychedelics illegal, and most experimentation, along with all research into their potential medicinal properties, came to a screeching halt.

Psychedelic drugs chart_03

Meanwhile, scientists have continued to experiment with the drugs in whatever capacity they can. Bogenschutz, one of the presenters at the New York psychedelic conference, has spent years studying the effects of a single dose of psychedelics on addicts. He’s found that in most cases, studies suggest the hallucinogens can improve mood, decrease anxiety, increase motivation, produce changes in personality, beliefs and values, and most importantly, decrease cravings. But how?

“One of the big questions was how would a single use produce lasting behavior change?” he said in 2014, “because if this is going to produce any lasting effect, there have to be consistent changes.”

Based on several small pilot studies that he’s helped conduct, Bogenschutz hypothesizes that the drugs affect addicts in two ways, which he breaks down into “acute” or short-term effects and “secondary”or longer-term effects. In the short-term, psychedelics affect our serotonin receptors, the brain’s main mood-regulatory neurotransmitters. Next, they affect our glutamate receptors, which appear to produce the so-called transformative experiences and psychological insight that people experience on the drugs.

“This is the most rewarding work I’ve ever done. To see these kinds of experiences … it’s just not as easy to get there with psychotherapy,” he said.

Staying in the light

From the time she was born, Clark Martin’s daughter and her father had a difficult relationship. He and his wife were never married, but they loved their child and divided their time with her as best they could. Still, Martin couldn’t help feel like their time together was consistently strained. For one thing, the spontaneity that’s so vital to many relationships was absent. He always knew when their time together started and when it was coming to an end.

“You’re not having as much everyday experience,” Martin recalled. “Instead you’re having kind of a planned experience. And that affects the depth of the relationship, I think.”

Green HillsMartin felt similarly about his father, who had developed Alzheimer’s several years before. Martin would visited when he could, but whenever they were together Martin felt compelled to try and push the visits into the confines of whatever he thought a “normal” father-son interaction should be. He’d try to make their discussions mirror the ones they would have had before his father became ill — “I kept trying to have ‘normal’ conversations with him,” Martin recalled.

About three hours into his psilocybin trip at Johns Hopkins, Martin called to mind a memory of his teenage daughter. “I’d been so focused on pursuing my own ideas about what was best for her,” he realized, “trying to be the architect of her life,” that he had let that get in the way of making sure she knew how much he loved and cared about her.

One afternoon about a year after the trip, Martin drove out to visit his father. This time, instead of trying to have a “normal” conversation with him, Martin took him for a drive.

“He always loved farming and ranching and we’d just get in the car and spend hours driving along,” Martin recalled.

As they drove, rolling green hills sped past them on all sides. His father looked out at the lush horizon with awe, as if he were seeing it for the first time. The crisp blue sky. The soft blanket of grass.

All of a sudden, Martin’s father saw something. He gestured out the window, but Martin saw nothing — just grass and trees and sky. Then, something moved in the distance. There, in the middle of two emerald hills, a deer cocked its head up.

“It was miles away,” said Martin. “I would have completely missed it.”

SEE ALSO: What magic mushrooms do to your body and brain

DON’T MISS: We’re on the cusp of an explosive change in how we treat one of America’s most ignored health problems

Join the conversation about this story »

NOW WATCH: What magic mushrooms do to your brain and state of mind

Technorati Tags: , , , , ,

4 reasons Microsoft Teams will kill Slack… and 4 reasons it won’t

Microsoft Teams is nearing its official debut. Designed as a hub for teamwork, the cloud-based Teams gives employees access to content, tools, people and conversations within the Office 365 environment. Groups and subgroups can communicate and collaborate using text-based chat, file sharing, and video and voice chats.

The big question is how Microsoft Teams will compete with Slack, a fan favorite in the hot enterprise team-collaboration market.

“If you look at the basics – if you took the two products as they are, side by side, without looking at any integrations or other ecosystem things – you wouldn’t really think one was overwhelmingly better than the other,” says Michael Fauscette, chief research officer at G2 Crowd, a peer-to-peer business software review platform. “There’s not a significant difference in the base product.”

To read this article in full or to leave a comment, please click here

(Insider Story)

Technorati Tags: , , , , ,

Google and Uber alums have created a doctor’s office that’s like an Apple Store meets ‘Westworld'

forward medical office startup 14

Somewhere between stepping into a full-body scanner that measures the elasticity of my veins and watching a cup used for urine samples disappear into the bathroom wall, I realize Forward is not your average doctor’s office. It’s like an Apple Store meets “Westworld.”

Staring down a massive touchscreen monitor in the exam room, I tell Adrian Aoun, founder and CEO of Forward, that I feel like I’m inside HBO’s sci-fi thriller.

“Yeah, but the good, not-creepy version, I hope,” Aoun says.

Forward emerged from stealth mode on January 17 to announce the opening of its first doctor’s office in San Francisco. The company offers a futuristic take on the popular concierge medical practice model, complete with state-of-the-art diagnostics tools, an AI system that listens and takes notes for physicians, and a pricey $149 monthly membership.

I recently toured Forward’s flagship location before opening to see what it was like.

SEE ALSO: After trying One Medical, I could never use a regular doctor again

This is what you get when several dozen former employees of Google, Facebook, Uber, and Palantir put their heads together to reinvent the doctor’s office.

About a year ago, Aoun was riding his bike to Google’s offices in Menlo Park, where he worked on artificial intelligence and ran the Special Projects division at Alphabet, when he got a call.

“Don’t freak out, but, I’m having a heart attack. I’m in an ambulance on my way to the hospital. So what do I do?” said his thirty-something relative over the sounds of sirens blaring.

After months of doctor’s appointments, phone calls with billing offices and insurance, and countless hours on Google trying to figure out what all the jargon meant, Aoun grew frustrated by how difficult the healthcare system was to navigate.

“Doctors are kind of awesome. They’re incredibly smart, they’re crazy well-educated. They mean well. … But the problem is, they’re totally set up for failure,” Aoun tells Business Insider.

“It’s kind of not their fault as much as, I would actually argue, it’s my fault. [If I’m] representing the engineering community, we totally dropped the ball,” he says.

His relative’s near-death experience was an eye-opener, Aoun says. He set out to bring more predictability, consistency, and convenience across the healthcare system.

He assembled a team of some of the most brilliant minds in Silicon Valley, including one of his cofounders, Ilya Abyzov, an early Uber employee who helped launch UberX.

Founded in 2016, Forward makes over every touchpoint in healthcare. The company’s engineers built everything from diagnostics tools to a mobile app that patients use to book appointments. The technology creates a better user experience for members and their doctors, according to Aaliya Yaqub, a Forward physician and a Facebook Health Center alum.

Forward’s vision has made an impression on venture capitalists. Its investors include Khosla Ventures, Peter Thiel’s Founders Fund, Eric Schmidt, and Marc Benioff.

Forward’s flagship location, which opened January 17, mimics the look and feel of an Apple Store. When members arrive, they sign in on an iPad at the reception desk.

See the rest of the story at Business Insider

Technorati Tags: , , , , ,

Apple is about to increase the price of apps in the UK by 25% because of Brexit (AAPL)

Tim Cook

Apple is increasing its App Store prices for apps and in-app purchases by more than 25% in the UK as a result of the post-Brexit fall in the pound, 9to5Mac reports, and the changes will hit in the next seven days.

It means that an app currently priced at £0.79 will increase to £0.99. And it’s likely the changes will hit the iTunes Store for TV shows, movies, and books, according to 9to5Mac.

It’s not the first time Apple has increased its prices in the UK to adjust for changes in the exchange rate — in October, it bumped up the prices for its new laptops significantly more in the UK compared to the US.

For instance, the 15-inch MacBook Pro increased £750 in the UK, compared to an increase of $400 (£330) in the US. And even existing Mac lines had their prices increased in the UK.

The price increase comes after Apple reported its busiest single day ever in the App Store on New Year’s Day this year, generating $240 million (£198 million) in sales.

Here’s Apple’s chart explaining the app price changes, via 9to5Mac:

Apple UK app store price increase

Revenues from sales in its App Store fall under Apple’s services revenues, and though they are currently dwarfed by its hardware sales, the recurring revenue from its services revenues is becoming increasingly important to Apple, according to analysts. 

By the middle of this year, iOS will reportedly have generated over $1 trillion (£815 billion) in its iOS revenues (that the operating platform across Apple’s hardware devices).

Join the conversation about this story »

NOW WATCH: 9 iPhone tricks that will make your life easier in 2017

Technorati Tags: , , , , ,

How to alert the police on the phone if it isn't safe to speak

If you’re ever in a situation where you need to alert the police but talking would put you in danger there is one simple thing that you need to know.

It is a protocol called Silent Solutions which decides whether or not police are dispatched to a silent call – of which they get thousands every day.

When you call 999 an operation will ask which emergency service you require, if you do not answer or make any indication that the call is an emergency the call will be put through to an automated system.

The system then asks for the caller to press “55” if the call is an emergency. If this is not done the call will end and the police will not attend.

A police spokesman said: “Please do not think that just because you dial 999 that police will attend.

“There must be some indication that the call has not been misdialled.”

Produced by Leon Siciliano

 

 

 

 

 

Join the conversation about this story »

Technorati Tags: , , , , ,

With change to cumulative Windows updates, Microsoft admits IE's fading role in the enterprise

Microsoft last week backtracked from a 2016 decision to offer Windows 7 and Windows 8.1 users only cumulative updates, saying on Friday that starting next month it will again provide Internet Explorer (IE) security patches as a separate download.

The change was a tacit admission by Microsoft that IE has lost its place of primacy in the enterprise, a fact supported by a disastrous decline in third-party measurements of the browser’s user and usage shares over the past year.

“Customers have requested increased flexibility for deploying the Security Only updates for Windows independently of the fixes for Internet Explorer,” Nathan Mercer, a Microsoft senior product marketing manager, wrote in a post to a company blog Jan. 13.

To read this article in full or to leave a comment, please click here

Technorati Tags: , , , , ,

New tool forces JavaScript code correctness

With a tool called Prettier, JavaScript formatting will get a consistent style.

An opinionated JavaScript formatter inspired by the refmt tool for formatting code, Prettier removes original styling and ensures outputted JavaScript conforms to a consistent style.

“Prettier gets rid of all original styling and guarantees consistency by parsing JavaScript into an AST (abstract syntax tree) and pretty-printing the AST,” developer James Long said. He noted that the tool makes it easier to write code however a developer wants because it can be instantly formatted correctly afterward.

To read this article in full or to leave a comment, please click here

Technorati Tags: , , , , ,

London startup Pact Coffee moved out of its office after failing to raise a £1 million crowdfunding round

Stephen Rapoport Pact Founder

Pact Coffee, a London startup that delivers fresh coffee to people in the UK, has moved out of its trendy office in South London.

The office was spread over two floors of an old Victorian biscuit factory, with exposed brickwork and original beams throughout. It also boasted a barista bar and enough space for cyclists to ride in straight off the street, according to TimeOut.

Founded in 2012 by Stephen Rapoport, Pact Coffee delivers freshly roasted coffee by post. The company says that its coffee is roast, ground, and shipped all within seven days.

The startup’s office, which housed up to 75 Pact Coffee employees at one point, has been taken over by neighbour Entrepreneur First — an organisation that helps individuals form deeply-technical companies through a 12-month startup programme.

Pact Coffee’s move comes after the startup failed to hit a £1 million crowdfunding target last March. The Crowdcube campaign was terminated early, with the company raising just £190,000, less than a fifth of its overall target. Pact Coffee cut 16 jobs shortly after terminating the campaign.

“As you know, we made 16 redundancies back in May 2016 and moved office as a result as we didn’t need so many desks,” Rapoport told Business Insider by email, adding that Pact Coffee has been in its new office for four months.

Rapoport added that “The Grindhouse” — home to Pact Coffee’s lab, roasting, grinding, and packaging — remains next to Pact Coffee’s old office. “It was only the lowly desk-jockeys like myself that moved.” The new office is a short walk from the old office and The Grindhouse.

ripe coffee beans

Pact Coffee has several thousand customers across the UK. When it announced the crowdfunding campaign, it said it wanted to raise more capital in order to scale-up, go international, and take advantage of a “home coffee” market that Pact Coffee believes to be worth over £1 billion.

Prior to the crowdfunding campaign, well-known investor Robin Klein invested in the company, as did venture capital firm MMC Ventures. To date, Pact Coffee has raised a total $8.1 million (£5.6 million).

“Pact has continued to grow steadily throughout the year,” Rapoport added. “When the time comes for a larger logistics facility, it will be a complex/costly operation to move but we’ve never shied away from a challenge.”

Join the conversation about this story »

NOW WATCH: ‘We watched our kids cry on Christmas’: Parents are furious after disaster with the holidays’ hottest toy

Technorati Tags: , , , , ,